Projects per year
Search results
-
Active
CAN-AUD: A multi-site randomised controlled trial of cannabidiol versus placebo for the management of treatment-resistant alcohol use disorder (the CAN-AUD trial)
Morley, K. C. (Chief Investigator (CI)), Haber, P. S. (Chief Investigator (CI)), Lintzeris, N. (Chief Investigator (CI)), Doyle, M. (Chief Investigator (CI)), Lubman, D. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Connor, J. P. (Chief Investigator (CI)), Lee, Y. Y. (Chief Investigator (CI)), Clark, P. (Chief Investigator (CI)), Slade, T. (Chief Investigator (CI)), Logge, W. (Associate Investigator (AI)), Watt, J. (Associate Investigator (AI)), Chatterton, M. L. (Associate Investigator (AI)), Towers, E. (Associate Investigator (AI)), Montebello, M. (Associate Investigator (AI)), Baillie, A. (Associate Investigator (AI)) & Morse, A. (Associate Investigator (AI))
1/07/25 → 30/06/29
Project: Research
File -
OLAM: Randomised double blind placebo controlled trial of oral lisdexamfetamine for methamphetamine withdrawal
Ezard, N. (Primary Chief Investigator (PCI)), Siefried, K. J. (Chief Investigator (CI)), Dunlop, A. (Chief Investigator (CI)), Lintzeris, N. (Chief Investigator (CI)), Shoptaw, S. (Chief Investigator (CI)), Haber, P. S. (Chief Investigator (CI)), Carr, A. D. (Chief Investigator (CI)), Doyle, M. F. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Clifford, M. (Chief Investigator (CI)), Levin, F. (Associate Investigator (AI)), Bonomo, Y. (Associate Investigator (AI)), Lubman, D. (Associate Investigator (AI)), Nagle, J. (Associate Investigator (AI)), Cox, D. (Associate Investigator (AI)), Moller, C. (Associate Investigator (AI)), Christmass, M. (Associate Investigator (AI)), Acheson, L. (Associate Investigator (AI)), McKetin, R. (Associate Investigator (AI)), Donoghoe, M. W. (Associate Investigator (AI)), Kuner, I. (Project Manager) & Logan, I. (Project Manager)
1/09/24 → 30/06/27
Project: Research
-
Scalable approaches to reducing alcohol and other drug use among traumatised young people: A RCT examining the safety, effectiveness, and cost-effectiveness of an integrated cognitivebehavioural therapy delivered via telehealth
Mills, K. L. (Primary Chief Investigator (PCI)), Cobham, V. E. (Chief Investigator (CI)), Peach, N. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Kay-Lambkin, F. (Chief Investigator (CI)), Chatterton, M. L. (Chief Investigator (CI)), Bendall, S. (Chief Investigator (CI)), Back, S. (Chief Investigator (CI)), Perrin , S. (Chief Investigator (CI)), Brady, K. T. (Chief Investigator (CI)), Kuner, I. (Project Manager) & Logan, I. (Project Manager)
1/01/23 → 31/12/26
Project: Research
-
Supporting vulnerable populations to maintain healthy ageing: Development of an enriched cohort study
Nielsen, S. (Primary Chief Investigator (PCI)), Lam, T. (Chief Investigator (CI)), Lalor, A. (Chief Investigator (CI)), Andrew, N. (Chief Investigator (CI)), Dietze, P. (Chief Investigator (CI)), Coulson, B. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Bright, S. J. (Chief Investigator (CI)), Hill, K. (Chief Investigator (CI)), Morgan, K. (Chief Investigator (CI)), Alfrey, L. (Chief Investigator (CI)) & Francia, L. (Chief Investigator (CI))
1/10/22 → 30/09/25
Project: Research
-
Transforming outcomes by investigating integrated treatment for methamphetamine use and trauma
Arunogiri, S. (Primary Chief Investigator (PCI))
1/07/22 → 30/06/28
Project: Research
-
Linking clinical and basic science discovery to find new treatments for alcohol use disorder
Haber, P. S. (Primary Chief Investigator (PCI)), Morley, K. C. (Chief Investigator (CI)), Lawrence, A. (Chief Investigator (CI)), Manning, V. (Chief Investigator (CI)), Lubman, D. (Chief Investigator (CI)), McNally, G. P. (Chief Investigator (CI)), Millan, Z. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Verdejo-Garcia, A. (Associate Investigator (AI)), Walker, L. (Associate Investigator (AI)), Logge, W. (Associate Investigator (AI)), Ogeil, R. (Associate Investigator (AI)), Leggio, L. (Associate Investigator (AI)), Kranzler, H. (Associate Investigator (AI)), Baillie, A. (Associate Investigator (AI)), Grunstein, R. R. (Associate Investigator (AI)), Perry, C. J. (Associate Investigator (AI)) & Bonomo, Y. (Associate Investigator (AI))
3/02/22 → 31/12/26
Project: Research
-
A randomised, double-blind, controlled trial of MDMA-assisted exposure therapy for alcohol use disorder and comorbid post-traumatic stress disorder
Morley, K. C. (Primary Chief Investigator (PCI)), Mills, K. (Chief Investigator (CI)), Haber, P. S. (Chief Investigator (CI)), Lubman, D. (Chief Investigator (CI)), Teesson, M. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Baillie, A. (Chief Investigator (CI)), Lee, Y. Y. (Chief Investigator (CI)), Morse, A. (Chief Investigator (CI)), Back, S. (Chief Investigator (CI)) & Liknaitzky, P. (Associate Investigator (AI))
1/01/22 → 31/12/25
Project: Research
-
Not started
MAGNET: Mental Health Australia General Clinical Trial Network (MAGNET)
Berk, M. (Primary Chief Investigator (PCI)), Rossell, S. L. (Chief Investigator (CI)), Fitzgerald, P. (Chief Investigator (CI)), O'Neil, A. (Chief Investigator (CI)), Turner, A. (Chief Investigator (CI)), Rodgers, A. (Chief Investigator (CI)), Mihalopoulos, C. (Chief Investigator (CI)), Ng, C. (Chief Investigator (CI)), Galletly, C. A. (Chief Investigator (CI)), Davey, C. G. (Chief Investigator (CI)), Harris, A. W. F. (Chief Investigator (CI)), Pantelis, C. (Chief Investigator (CI)), Loo, C. K. (Chief Investigator (CI)), Lubman, D. (Chief Investigator (CI)), Siskind, D. (Chief Investigator (CI)), Forbes, D. (Chief Investigator (CI)), Meyer, D. (Chief Investigator (CI)), Jacka, F. N. (Chief Investigator (CI)), Kay-Lambkin, F. (Chief Investigator (CI)), Malhi, G. S. (Chief Investigator (CI)), Murray, G. W. (Chief Investigator (CI)), Christensen, H. (Chief Investigator (CI)), Kulkarni, J. (Chief Investigator (CI)), Sarris, J. (Chief Investigator (CI)), Lagopoulos, J. (Chief Investigator (CI)), McGrath, J. J. (Chief Investigator (CI)), Hoy, K. (Chief Investigator (CI)), Mills, K. (Chief Investigator (CI)), Nelson, M. R. (Chief Investigator (CI)), O’Donnell, M. L. (Chief Investigator (CI)), Gunn, J. M. (Chief Investigator (CI)), Millard, M. (Chief Investigator (CI)), Kyrios, M. (Chief Investigator (CI)), Yucel, M. (Chief Investigator (CI)), Glozier, N. (Chief Investigator (CI)), Martin, N. (Chief Investigator (CI)), Dean, O. M. (Chief Investigator (CI)), Almeida, O. (Chief Investigator (CI)), Batterham, P. J. (Chief Investigator (CI)), McKetin, R. (Chief Investigator (CI)), Bryant, R. A. (Chief Investigator (CI)), Osborne, R. H. (Chief Investigator (CI)), Harvey, S. (Chief Investigator (CI)), Hood, S. (Chief Investigator (CI)), Touyz, S. W. (Chief Investigator (CI)), Sundram, S. (Chief Investigator (CI)), Apostolopoulos, V. (Chief Investigator (CI)), Zoungas, S. (Chief Investigator (CI)), Venkatesh, S. (Chief Investigator (CI)), Russell, S. (Chief Investigator (CI)), Poynton, A. (Project Manager) & Arunogiri, S. (Associate Investigator (AI))
Project: Research
-
Finished
Acceptability and efficacy of app-based Resonant Breathing practice for reducing craving and alcohol consumption
Lubman, D. (Primary Chief Investigator (PCI)), Manning, V. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Catchlove, S. (Chief Investigator (CI)) & Roxburgh, A. (Chief Investigator (CI))
10/10/23 → 9/04/25
Project: Research
-
A randomised controlled trial of cannabidiol (CBD) in the treatment of cannabis dependence
Lintzeris, N. (Primary Chief Investigator (PCI)), Lubman, D. (Chief Investigator (CI)), Doyle, M. F. (Chief Investigator (CI)), Dunlop, A. (Chief Investigator (CI)), Mills, L. (Chief Investigator (CI)), Harrod, M. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Malouf, P. (Chief Investigator (CI)), Haber, P. S. (Chief Investigator (CI)), Freeman, T. (Chief Investigator (CI)), Solowij, N. (Associate Investigator (AI)), Graham, R. (Associate Investigator (AI)), Childs, S. (Associate Investigator (AI)), Ella, S. (Associate Investigator (AI)), Montebello, M. (Associate Investigator (AI)), Nean, M. (Associate Investigator (AI)), Galettis, P. (Associate Investigator (AI)), Reeves, P. (Associate Investigator (AI)), Monds, L. A. (Associate Investigator (AI)) & Jefferies, M. (Associate Investigator (AI))
NHMRC - National Health and Medical Research Council (Australia)
1/07/22 → 30/06/25
Project: Research
-
A randomised controlled trial of N-acetylcysteine for the treatment of alcohol use disorder
Morley, K. C. (Primary Chief Investigator (PCI)), Haber, P. S. (Chief Investigator (CI)), Lubman, D. (Chief Investigator (CI)), Berk, M. (Chief Investigator (CI)), Baillie, A. (Chief Investigator (CI)), Connor, J. P. (Chief Investigator (CI)), Slade, T. (Chief Investigator (CI)), Chatterton, M. L. (Chief Investigator (CI)), Clark, P. J. (Chief Investigator (CI)) & Arunogiri, S. (Chief Investigator (CI))
1/07/21 → 30/06/25
Project: Research
-
A Phase III randomised placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine (“Ice”) dependence
McKetin, R. (Primary Chief Investigator (PCI)), Arunogiri, S. (Chief Investigator (CI)), Farrell, M. P. (Chief Investigator (CI)), Degenhardt, L. (Chief Investigator (CI)), Dore, G. J. (Chief Investigator (CI)), Colledge, S. (Chief Investigator (CI)), Kelly, P. J. (Chief Investigator (CI)), Turner, A. (Chief Investigator (CI)) & Clare, P. J. (Chief Investigator (CI))
1/06/21 → 31/05/25
Project: Research
-
A pilot randomised controlled trial (RCT) of personalised approach bias modification for methamphetamine use disorder
Manning, V. (Primary Chief Investigator (PCI)), Garfield, J. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Lubman, D. (Chief Investigator (CI)), Gavin, J. (Chief Investigator (CI)), Kotler, E. (Chief Investigator (CI)), George, S. (Chief Investigator (CI)), Okedara, G. (Chief Investigator (CI)) & Hopwood, M. (Chief Investigator (CI))
National Centre for Clinical Research on Emerging Drugs
24/01/20 → 31/03/22
Project: Research
-
A randomised controlled trial of telephone-delivered psychological treatment to reduce methamphetamine use
Lubman, D. (Primary Chief Investigator (PCI)), Manning, V. (Chief Investigator (CI)), Hall, K. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Grigg, J. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)) & Harris, A. (Chief Investigator (CI))
1/01/20 → 31/12/23
Project: Research
-
Women's Voice @ Turning Point: A platform for meaningful consumer representation in addiction treatment for women at risk of homelessness
Arunogiri, S. (Primary Chief Investigator (PCI))
1/01/20 → 31/12/20
Project: Research
-
Sex hormones, mood and alcohol use in women: towards a novel treatment target
Arunogiri, S. (Primary Chief Investigator (PCI)), Gurvich, C. (Chief Investigator (CI)), Kulkarni, J. (Chief Investigator (CI)) & Lubman, D. (Chief Investigator (CI))
Monash University – Internal Department Contribution
23/09/19 → 30/09/20
Project: Research
-
Investigating the role of social cognition in hostility and violence in methamphetamine use and psychosis
Arunogiri, S. (Primary Chief Investigator (PCI))
Society for Mental Health Research Inc
5/02/18 → 31/12/18
Project: Research
-
Development of the Methamphetamine Treatment Guidelines
Grigg, J. (Primary Chief Investigator (PCI)), Manning, V. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Volpe, I. (Chief Investigator (CI)), Frei, M. (Chief Investigator (CI)), Phan, V. (Chief Investigator (CI)), Rubenis, A. (Chief Investigator (CI)), Dias, S. (Chief Investigator (CI)), Petrie, M. (Chief Investigator (CI)), Sharkey, M. (Chief Investigator (CI)) & Lubman, D. (Chief Investigator (CI))
1/06/17 → 30/06/18
Project: Research
File -
Development of evidence summary for a new treatment model for synthetic cannabinoid use problems
Grigg, J. (Primary Chief Investigator (PCI)), Lubman, D. (Chief Investigator (CI)), Manning, V. (Chief Investigator (CI)) & Arunogiri, S. (Chief Investigator (CI))
30/09/16 → 30/09/17
Project: Research
File -
Methamphetamine and psychosis: understanding risk factors
Arunogiri, S. (Primary Chief Investigator (PCI))
1/01/16 → 31/12/17
Project: Research
-
The investigation of markers of relapse and potential therapeutic targets in methamphetamine dependence using novel techniques
Arunogiri, S. (Primary Chief Investigator (PCI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/15 → 31/03/17
Project: Research